living with friedreich’s ataxia: the loneliness of losing control
“the biggest thing is the social aspect, and he doesn’t want to be alone. he just wants those friendships."
subset of als patients find hope through newly approved medication
the new drug is only available for two per cent of als patients, but it does open the door for research into new therapies for others with als.
rare disease day 2025: slow movement on billion-dollar pledge for rare disease drugs is leaving canadians behind
close to two years ago, the government of canada announced $1.5 billion in funding for the first-of-its-kind national strategy for drugs for rare diseases.